Netflix (NFLX) January put option implied volatility is low at 42, February is at 57; compared to its 26-week average of 52, according to Track Data, suggesting decreasing near-term price movement.

China Valves Technology (CVVT) overall option implied volatility of 61 is near its 26-week average, according to Track Data, suggesting nondirectional price movement.

Wonder Auto (WATG) overall option implied volatility of 68 is near its 26-week, average according to Track Data, suggesting nondirectional price movement.

Analyst Upgrades

• JMP Securities upgraded Boston Properties (BXP) to outperform from market perform and has an $89 price target on the stock. The firm upgraded shares based on near-term catalysts that include, the potential start of 1msf of development in Midtown, investments, and selection as 1 World Trade Center project manager.
• Baird upgraded Bucyrus (BUCY) to outperform from neutral, citing valuation and an a more favorable view of the Terex Mining acquisition. The firm has an $83 price target on the stock.
• Jefferies upgraded Warner Chilcott (WCRX) to buy from hold and has a $30 price target on the stock. The firm upgraded shares based on valuation and conservative guidance.
• AmeriCredit (ACF) was upgraded to market perform from underperform at Keefe Bruyette.
• Royal Dutch Shell (RDS.A) was upgraded to overweight from neutral at JPMorgan.
• Rio Tinto (RTP) was upgraded to outperform from market perform at Bernstein.

Analyst Upgrades

• Baird upgraded Intel (INTC) to outperform from neutral and has a $26 target on the stock. The firm's checks indicate tier-one PC OEMs have raised their 1H10 procurement forecasts, which could lead to Intel outperformance.
• Citigroup upgraded UnitedHealth (UNH) to buy from hold on expectations the company will benefit from a sector rotation into Managed Care in 2010. The firm raised its price target on shares to $39 from $30.
• UBS upgraded Morgan Stanley (MS) to buy from neutral based on strong capital and liquidity positions, building investment banking pipelines, and expectations for a turn in EPS/ROE, among other reasons.
• Deutsche Bank upgraded the U.S. Refining group as it believes demand is improving and margins could expand in 2010. The firm raised its rating on Sunoco (SUN) to hold from sell and its target on shares to $25 from $18, and upgraded Tesoro (TSO) and Frontier Oil (FTO) to buy from hold.
• Boeing (BA) was raised to overweight from equal weight at Barclays.
• Wynn Resorts (WYNN) was upgraded at UBS to buy from neutral.
• Investors Bancorp (ISBC) was upgraded to buy from neutral at Janney Montgomery.

Analyst upgrades:

• Target (NYSE: TGT) was upgraded two ratings to Buy from Sell at Citigroup, and it raised its price estimate on shares to $61 from $44. The firm sees significant earnings upside as the company's same-store sales improve and finds the valuation attractive at current levels.
• Motorola (NYSE: MOT) was upgraded to Outperform from Sector Perform at RBC Capital citing valuation, new product launches, and expectations that the Mobile Devices division will be profitable. The price target is $11.
• AK Steel (NYSE: AKS) was upgraded to Buy from Hold at Citigroup as it believes the company's Q3 results were solid and the China steel market is stabilizing. The firm raised its target to $21 from $17.
• Ceradyne (NASDAQ: CRDN) was upgraded at Wells Fargo to Market Perform from Underperform. The firm thinks that earnings expectations for the company have now reached more reasonable levels, limiting risk.
• FormFactor (NASDAQ: FORM) was upgraded to Outperform from Market Perform at FBR Capital ahead of the company's Q3 results due to valuation as it views the risk/reward on shares compelling. The firm raised its price target to $25 from $19.
• Texas Instruments (NYSE: TXN) was upgraded at Goldman to Buy from Neutral, citing 2H10 margin expansion and analog share gains. Target was raised to $29 from $27.
• Barrett Business Services (NASDAQ: BBSI) was upgraded to Buy from Hold at Roth Capital as the firm thinks the company will benefit from a labor market recovery next year. Roth notes that the stock's valuation has lagged behind most of its peers in recent months and it set an $18 target.